Contineum Therapeutics, Inc. (CTNM)

NASDAQ: CTNM · IEX Real-Time Price · USD

20.69

-0.31 (-1.48%)

At close: Jul 2, 2024, 4:00 PM

20.29

-0.40 (-1.93%)

After-hours: Jul 2, 2024, 4:57 PM EDT

Contineum Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022
Net Income	3.15	-24.25
Depreciation & Amortization	1.16	1.26
Share-Based Compensation	2.22	1.93
Other Operating Activities	12.82	0.95
Operating Cash Flow	19.35	-20.12
Capital Expenditures	-0.41	-0.12
Change in Investments	-65.15	22.42
Investing Cash Flow	-65.57	22.3
Share Issuance / Repurchase	0.13	0.01
Debt Issued / Paid	-3.75	-1.25
Other Financing Activities	59.8	-
Financing Cash Flow	56.18	-1.24
Net Cash Flow	9.96	0.94
Free Cash Flow	18.94	-20.24
Free Cash Flow Margin	37.87%	-
Free Cash Flow Per Share	8.20	-9.02

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).